Research Article
No access
Published Online: 28 August 2012

Ramadan Fasting in Diabetes Patients on Insulin Pump Therapy Augmented by Continuous Glucose Monitoring: An Observational Real-Life Study

Publication: Diabetes Technology & Therapeutics
Volume 14, Issue Number 9

Abstract

Background and Aims: Hypoglycemia during the daytime of Ramadan fasting is the most feared complication of diabetes. Insulin pump therapy has been proposed as the ideal “theoretical” method for insulin delivery. We report a prospective observational, single-center study of insulin-treated patients using insulin pump therapy during Ramadan 2011.
Patients and Methods: Twenty-one patients (10 males and 11 females) were selected; median age was 26 years. They adjusted their insulin as per their usual practices. Outcome measures obtained before and during Ramadan included body weight, glycosylated hemoglobin, blood glucose, total insulin dose differences, overriding tendency, suspension time during fasting, and number of hypoglycemic episodes.
Results: The patients fasted for a median of 29 days. The observed changes during Ramadan were overall not significant quantitatively, but some trends were noted. The total insulin administered during Ramadan was not different from that in the pre-Ramadan period, but there was a redistribution of insulin over a 24-h period in relation to the changes in the daily lifestyle and eating patterns. Basal insulin was decreased during the daytime by 5–20% from before Ramadan and increased during the nighttime. The mean change in the overall amount of basal insulin was not significant. A larger than usual amount of insulin bolus was given at the meals Iftar, Fowala, and Suhur; the change in the total amount of bolus insulin as a percentage change from total insulin was also not significant. No major hypoglycemic episodes were reported. Minor hypoglcemic episodes were equally distributed between daytime and nighttime and were managed by either basal insulin adjustment or suspension from the pump.
Conclusions: This study confirms the advantages provided by insulin pump use in patients with diabetes were enhanced by the use of continuous glucose monitoring. We provided more evidence-based advice on how best to adjust the insulin pump during fasting.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
The Holy QuranSura2183-185. 1. The Holy Quran. Sura 2:183–185.
2.
Sulimani RA. Ramadan fasting: medical aspects in health and in diseaseAnn Saudi Med199111637-641. 2. Sulimani RA: Ramadan fasting: medical aspects in health and in disease. Ann Saudi Med 1991;11:637–641.
3.
Beshyah SA. Fasting Ramadan for people with diabetes: medicine and Fiqh united at lastIbnosina J Med Biomed Sci200911-5. 3. Beshyah SA: Fasting Ramadan for people with diabetes: medicine and Fiqh united at last. Ibnosina J Med Biomed Sci 2009;1:1–5.
4.
Salti IBénard EDetournay BBianchi-Biscay MLe Brigand CVoinet CJabbar AEPIDIAR Study Group. A population based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) studyDiabetes Care2004272306-2311. 4. Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A; EPIDIAR Study Group: A population based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004;27:2306–2311.
5.
Beshyah SABenbarka MMSherif I. Practical management of diabetes during Ramadan fastLibyan J Med20082185-189. 5. Beshyah SA, Benbarka MM, Sherif I: Practical management of diabetes during Ramadan fast. Libyan J Med 2008;2:185–189.
6.
Beshyah SASherif I. Diabetes during Ramadan and HajLakhdar AAGill GVDiabetes in the Arab WorldCambridge, UKFSG Communications Ltd.2005225-240. 6. Beshyah SA, Sherif I: Diabetes during Ramadan and Haj. In: Lakhdar AA, Gill GV, eds. Diabetes in the Arab World. Cambridge, UK: FSG Communications Ltd., 2005:225–240.
7.
Benaji BMounib NRoky RAadil NHouti IEMoussamih SMaliki SGressier BEl Ghomari H. Diabetes and Ramadan: review of the literatureDiabetes Res Clin Pract200673117-125. 7. Benaji B, Mounib N, Roky R, Aadil N, Houti IE, Moussamih S, Maliki S, Gressier B, El Ghomari H: Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract 2006;73:117–125.
8.
Diabetes and Ramadan Advisory Board. International Medical Recommendations for Muslim subjects with diabetes mellitus who fast during the month of RamadanClin Diabetes (Middle East Ed)20043143-145. 8. Diabetes and Ramadan Advisory Board: International Medical Recommendations for Muslim subjects with diabetes mellitus who fast during the month of Ramadan. Clin Diabetes (Middle East Ed) 2004;3:143–145.
9.
Al-Arouj MBouguerra RBuse JHafez SHassanein MIbrahim MAIsmail-Beigi FEl-Kebbi IKhatib OKishawi SAl-Madani AMishal AAAl-Maskari MNakhi ABAl-Rubean K. Recommendations for management of diabetes during RamadanDiabetes Care2005282305-2311. 9. Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA, Ismail-Beigi F, El-Kebbi I, Khatib O, Kishawi S, Al-Madani A, Mishal AA, Al-Maskari M, Nakhi AB, Al-Rubean K: Recommendations for management of diabetes during Ramadan. Diabetes Care 2005;28:2305–2311.
10.
Al-Arouj MAssaad-Khalil SBuse JFahdil IFahmy MHafez SHassanein MIbrahim MAKendall DKishawi SAl-Madani ANakhi ABTayeb KThomas A. Recommendations for management of diabetes during Ramadan: update 2010Diabetes Care2010331895-1902. 10. Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, Hassanein M, Ibrahim MA, Kendall D, Kishawi S, Al-Madani A, Nakhi AB, Tayeb K, Thomas A: Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010;33:1895–1902.
11.
Benbarka MMKhalil ABBeshyah SAMarjei SAwad SA. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational reportDiabetes Technol Ther201012287-290. 11. Benbarka MM, Khalil AB, Beshyah SA, Marjei S, Awad SA: Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report. Diabetes Technol Ther 2010;12:287–290.
12.
Bin-Abbas BSSakati NARaef HAl-Ashwal AAContinuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapySaudi Med J200526918-922. 12. Bin-Abbas BS, Sakati NA, Raef H, Al-Ashwal AA: Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy. Saudi Med J 2005;26:918–922.
13.
Bin-Abbas BS. Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescentsAnn Saudi Med200828305-306. 13. Bin-Abbas BS: Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescents. Ann Saudi Med 2008;28:305–306.
14.
Lessan NGAbdullah AAl Mousavi HNasir QAthamneh S. Utility of continuous glucose monitoring (CGMS) to explore glycemic patterns in patients with diabetes mellitus in the UAE [abstract]Endocr Abstr200611P324. 14. Lessan NG, Abdullah A, Al Mousavi H, Nasir Q, Athamneh S: Utility of continuous glucose monitoring (CGMS) to explore glycemic patterns in patients with diabetes mellitus in the UAE [abstract]. Endocr Abstr 2006;11:P324.
15.
Azar STKhairallah WGMerheb MTZantout MSFliti F. Insulin therapy during Ramadan fast for patients with type 1 diabetes mellitusJ Med Liban20085646. 15. Azar ST, Khairallah WG, Merheb MT, Zantout MS, Fliti F: Insulin therapy during Ramadan fast for patients with type 1 diabetes mellitus. J Med Liban 2008;56:46.
16.
Kassem HSZantout MSAzar ST. Insulin therapy during Ramadan fast for Type 1 diabetes patientsJ Endocrinol Invest200528802-805. 16. Kassem HS, Zantout MS, Azar ST: Insulin therapy during Ramadan fast for Type 1 diabetes patients. J Endocrinol Invest 2005;28:802–805.
17.
Ahmed MHAbdu TA. Diabetes and Ramadan: an update on use of glycemic therapies during fastingAnn Saudi Med201131402-406. 17. Ahmed MH, Abdu TA: Diabetes and Ramadan: an update on use of glycemic therapies during fasting. Ann Saudi Med 2011;31:402–406.
18.
Pickup J. Insulin pumpsInt J Clin Pract Suppl201117016-19. 18. Pickup J: Insulin pumps. Int J Clin Pract Suppl 2011;170:16–19.
19.
Merheb MChaiban JSalti ISammak IChoucair MNasrallah M. Insulin pump therapy in type 1 diabetic patients: experience at the American University of Beirut Medical CenterInt J Diabetes Metab20081657-61. 19. Merheb M, Chaiban J, Salti I, Sammak I, Choucair M, Nasrallah M: Insulin pump therapy in type 1 diabetic patients: experience at the American University of Beirut Medical Center. Int J Diabetes Metab 2008;16:57–61.
20.
Ooi HLWu LL. Insulin pump therapy in children and adolescents with Type 1 diabetes: improvements in glycemic control and patients' satisfaction—Hospital UKM experienceMed J Malaysia201166308-312. 20. Ooi HL, Wu LL: Insulin pump therapy in children and adolescents with Type 1 diabetes: improvements in glycemic control and patients' satisfaction—Hospital UKM experience. Med J Malaysia 2011;66:308–312.
21.
Sherif IHLakhdar AF. Ramadan fasting and the medical patient: consensus is welcome but more evidence is neededIbnosina J Med Biomed Sci20102237-239. 21. Sherif IH, Lakhdar AF: Ramadan fasting and the medical patient: consensus is welcome but more evidence is needed. Ibnosina J Med Biomed Sci 2010;2:237–239.
22.
Jayasekara RSMunn ZLockwood C. Effect of educational components and strategies associated with insulin pump therapy: a systematic reviewInt J Evid Based Healthc20119346-361. 22. Jayasekara RS, Munn Z, Lockwood C: Effect of educational components and strategies associated with insulin pump therapy: a systematic review. Int J Evid Based Healthc 2011;9:346–361.
23.
Garg SBrazg RLBailey TSBuckingham BASlover RHKlonoff DCShin JWelsh JBKaufman FR. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE studyDiabetes Technol Ther201214205-209. 23. Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR: Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther 2012;14:205–209.
24.
Agrawal PWelsh JBKannard BAskari SYang QKaufman FR. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pumpJ Diabetes Sci Technol201151137-1141. 24. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR: Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol 2011;5:1137–1141.

Information & Authors

Information

Published In

cover image Diabetes Technology & Therapeutics
Diabetes Technology & Therapeutics
Volume 14Issue Number 9September 2012
Pages: 813 - 818
PubMed: 22827507

History

Published in print: September 2012
Published online: 28 August 2012
Published ahead of print: 24 July 2012

Permissions

Request permissions for this article.

Authors

Affiliations

Ali Bernard Khalil
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Salem A. Beshyah
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Samar M. Abu Awad
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Mahmoud M. Benbarka
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Marcil Haddad
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Dana Al-Hassan
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Marwa Kahwatih
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Nico Nagelkerke
United Arab Emirates University, Al Ain, United Arab Emirates.

Notes

Address correspondence to:Ali Khalil, MD, FRCP, FACEConsultant EndocrinologistSheikh Khalifa Medical CityP.O. Box 51900Al Karameh StreetAbu Dhabi,United Arab Emirates
E-mail: [email protected]

Author Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top